AGENUS INC

AGEN

AGENUS INC

AGEN

Insider Sentiment (TTM):

Last Purchase:2024-02-15Last Sale:2022-01-06Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:8,968,098Shares Outstanding:37,941,000Institutional Ownership Pct.:23.64%

Earnings Market Reaction:

Filing Date:2026-08-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	19	35	3	3	10	18	40	45	94	53	76	106
Escrow Deposit	8	8	-	-	-	-	-	-	-	-	-	-
Accounts Receivable Net Current	15	7	2	1	1	0	0	0	1	0	26	1
Notes Receivable Net	-	-	5	6	-	-	-	-	-	-	-	-
Prepaid Expense Current	3	4	1	1	1	2	2	2	2	4	8	16
Assets Held For Sale Not Part Of Disposal Group Cu…	0	0	122	122	-	-	0	-	-	-	-	-
Other Assets Current	2	2	1	1	2	2	2	3	3	3	2	2
Assets Current	79	95	133	134	13	23	46	50	100	60	112	126
Property Plant And Equipment Net	14	15	15	16	113	117	120	124	128	130	133	140
Operating Lease Right Of Use Asset	7	7	8	8	26	27	27	29	29	29	30	30
Goodwill	24	24	24	24	24	24	24	25	25	25	25	25
Intangible Assets Net Excluding Goodwill	3	3	3	3	3	3	3	4	4	4	4	4
Equity Method Investments	25	23	24	30	-	-	0	-	-	-	-	-
Other Assets Noncurrent	4	3	3	3	5	6	6	7	7	8	9	11
Assets	173	186	227	234	185	200	226	238	292	257	314	335
Liabilities And Stockhold…
Long Term Debt Current	30	30	45	11	11	1	3	13	13	14	0	0
Contract With Customer Liability Current	-	-	0	0	0	0	0	0	0	0	0	5
Operating Lease Liability Current	1	1	1	1	2	3	2	2	2	3	3	3
Accounts Payable Current	59	71	83	85	74	64	61	46	51	51	61	41
Accrued Liabilities Current	28	37	34	32	39	36	35	37	41	41	45	38
Other Liabilities Current	0	1	1	1	4	5	8	13	16	14	14	13
Liabilities Current	232	249	323	287	235	208	221	271	271	256	256	198
Long Term Debt Noncurrent	-	-	0	24	23	33	30	0	0	0	13	13
Contract With Customer Liability Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Operating Lease Liability Noncurrent	10	10	10	10	53	54	55	55	56	62	63	63
Other Liabilities Noncurrent	0	0	0	0	1	1	1	1	1	3	5	8
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	4
Additional Paid In Capital	1,945	1,922	1,912	1,899	1,883	1,868	1,858	1,846	1,830	1,817	1,796	1,777
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-2	-2	-1	-1	-1	-1	-1	-1	-1
Retained Earnings Accumulated Deficit	-2,144	-2,144	-2,183	-2,172	-2,236	-2,208	-2,183	-2,137	-2,071	-2,018	-1,956	-1,909
Stockholders Equity	-206	-221	-278	-274	-355	-322	-326	-272	-221	-190	-148	-115
Minority Interest	-7	-7	-7	-7	18	19	20	21	20	11	12	14
Liabilities And Stockholders Equity	173	186	227	234	185	200	226	238	292	257	314	335
Accumulated Depreciation Depletion And Amortizatio…	48	48	47	47	75	76	73	71	68	65	62	61
Finite Lived Intangible Assets Accumulated Amortiz…	17	17	17	17	17	17	17	18	18	18	18	17
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	-	-	-	0.01	-	-	-	0.01	-
Preferred Stock Shares Authorized	5	5	5	-	-	-	5	-	-	-	5	-
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	800	800	800	800	800	800	800	800	800	800	800	800
Common Stock Shares Issued	43	39	35	33	30	27	24	22	21	21	20	381
Shares Outstanding	43	39	35	33	30	27	24	22	21	21	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-0.92%	7.06%	130.06%	-	-	-	-	-	-	-	-	-
2025	70.00%	73.43%	53.14%	1.41%	-3.04%	-7.03%	-6.65%	-23.28%	-32.54%	20.36%	16.11%	-1.82%
2024	30.64%	39.47%	-45.38%	-2.46%	0.57%	-17.61%	15.11%	5.14%	22.19%	-4.49%	63.48%	234.27%
2023	-	-	-	11.20%	-9.60%	-37.60%	4.00%	10.67%	-12.00%	-16.67%	8.92%	30.75%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.34	0.38	0.41	0.47	0.06	0.11	0.21	0.19	0.37	0.24	0.44	0.63
Quick Ratio	0.33	0.37	0.41	0.46	0.05	0.10	0.20	0.18	0.36	0.22	0.41	0.55
Working Capital	-153.01M	-153.95M	-190.05M	-153.18M	-221.22M	-185.17M	-175.83M	-220.49M	-170.66M	-195.65M	-143.48M	-72.81M
Leverage & Debt
Debt to Equity	-1.13	-1.13	-1.16	-1.05	-0.66	-0.65	-0.72	-1.00	-1.23	-1.35	-1.72	-1.72
Interest Coverage TTM	0.61	0.14	-0.36	-1.01	-1.06	-1.00	-1.02	-0.70	-0.92	-1.25	-1.63	-3.00
Debt Ratio	1.34	1.34	1.43	1.23	1.27	1.04	0.98	1.13	0.93	1.00	0.82	0.59
Efficiency & Turnover
Asset Turnover TTM	0.74	0.64	0.50	0.45	0.43	0.44	0.38	0.56	0.47	0.48	0.43	0.26
Days Sales Outstanding TTM	21.23	10.19	3.58	1.27	2.56	1.52	46.29	1.41	2.36	2.14	33.36	17.82
Receivables Turnover TTM	17.19	35.82	102.05	286.79	142.45	239.82	7.88	259.38	154.98	170.54	10.94	20.48
Per Share Metrics
Diluted EPS TTM	2.25	1.71	-0.00	-1.06	-5.88	-7.78	-10.59	-10.95	-11.11	-12.27	-14.39	-14.31
Free Cash Flow Per Share TTM	-2.38	-2.31	-2.60	-2.80	-4.55	-5.98	-7.40	-7.93	-8.84	-10.41	-13.09	-13.50
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	101.07%	100.63%	100.52%	100.47%	100.39%	100.49%	100.57%	101.99%	110.45%
Operating Profit Margin TTM	27.28%	6.62%	-17.66%	-56.60%	-85.96%	-101.39%	-116.44%	-61.57%	-71.18%	-85.55%	-102.07%	-211.21%
Net Profit Margin TTM	69.97%	52.83%	-0.09%	-32.64%	-162.45%	-191.25%	-219.81%	-147.09%	-146.63%	-154.88%	-164.69%	-268.26%
Growth Metrics
Net Revenue Growth (1Y)	30.47%	24.46%	10.37%	-33.41%	-36.29%	-38.34%	-33.81%	59.00%	60.67%	69.94%	59.47%	12.23%
Net Income Growth (1Y)	-156.20%	-134.38%	-99.96%	-85.22%	-29.41%	-23.86%	-11.66%	-12.82%	-10.12%	3.92%	16.86%	24.27%
EPS Growth (1Y)	-138.22%	-122.17%	-99.97%	-90.01%	-47.12%	-36.62%	-26.38%	-23.51%	-25.02%	-19.11%	-98.16%	-98.11%
Valuation Metrics
P/E TTM	1.36	1.94	-924.40	-3.52	-0.78	-0.19	-0.26	-0.50	-1.51	-0.95	-1.15	-1.58
P/B TTM	-0.61	-0.57	-0.34	-0.45	-0.36	-0.11	-0.19	-0.43	-1.60	-1.24	-2.00	-3.71
P/S TTM	0.95	1.02	0.82	1.15	1.26	0.37	0.57	0.74	2.21	1.46	1.90	4.24
Market Cap	126.49M	126.72M	93.36M	122.76M	128.49M	36.95M	58.84M	118.09M	352.79M	236.27M	297.04M	427.32M
Enterprise Value	137.82M	121.92M	90.37M	153.51M	152.83M	52.04M	51.57M	86.71M	272.49M	196.99M	233.84M	334.12M
Calculated Values
Free Cash Flow TTM	-98.50M	-87.53M	-77.20M	-89.31M	-127.87M	-146.29M	-158.89M	-170.79M	-186.18M	-212.01M	-234.16M	-255.22M
Net Debt	11.33M	-4.80M	-3.00M	30.75M	24.34M	15.09M	-7.27M	-31.38M	-80.30M	-39.28M	-63.20M	-93.20M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-02-15Purchase

Owner: Armen, Garo H

Title: See Remarks

Shares: 500,000

Price/Share: $0.65

Value: $325,000.00

Shares Owned: 625,969

Relationship: Director,Officer

Ownership: Indirect

2023-11-15Purchase

Owner: Wiinberg, Ulf

Title: -

Shares: 25,000

Price/Share: $0.76

Value: $19,000.00

Shares Owned: 124,063

Relationship: Director

Ownership: Direct

2022-01-06Sale

Owner: O'Day, Steven J

Title: Chief Medical Officer

Shares: 38,679

Price/Share: $3.06

Value: $118,357.74

Shares Owned: 61,321

Relationship: Officer

Ownership: Direct

2021-09-13Sale

Owner: Armen, Garo H

Title: Chairman and CEO

Shares: 82,107

Price/Share: $6.50

Value: $533,695.50

Shares Owned: 770,773

Relationship: Director,Officer

Ownership: Direct

2021-09-10Sale

Owner: Klaskin, Christine M

Title: PFO & PAO

Shares: 11,120

Price/Share: $6.50

Value: $72,280.00

Shares Owned: 93,056

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-02-15	Armen, Garo H	Director,Officer	See Remarks	Indirect	Purchase	500,000	0.65	$325,000.00	625,969	4
2023-11-15	Wiinberg, Ulf	Director	-	Direct	Purchase	25,000	0.76	$19,000.00	124,063	4
2022-01-06	O'Day, Steven J	Officer	Chief Medical Officer	Direct	Sale	38,679	3.06	$118,357.74	61,321	4
2021-09-13	Armen, Garo H	Director,Officer	Chairman and CEO	Direct	Sale	82,107	6.50	$533,695.50	770,773	4
2021-09-10	Klaskin, Christine M	Officer	PFO & PAO	Direct	Sale	11,120	6.50	$72,280.00	93,056	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

23.64%

Inst. Shares: 8,968,098

Shares Outstanding: 37,941,000

2025-12-31

32.58%

Inst. Shares: 9,687,348

Shares Outstanding: 29,734,000

2025-09-30

26.85%

Inst. Shares: 8,561,719

Shares Outstanding: 31,886,000

2025-06-30

31.56%

Inst. Shares: 8,873,719

Shares Outstanding: 28,117,000

2025-03-31

34.06%

Inst. Shares: 8,335,269

Shares Outstanding: 24,469,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	8,968,098	37,941,000	23.64%
2025-12-31	9,687,348	29,734,000	32.58%
2025-09-30	8,561,719	31,886,000	26.85%
2025-06-30	8,873,719	28,117,000	31.56%
2025-03-31	8,335,269	24,469,000	34.06%
2024-12-31	8,206,047	21,473,000	38.22%
2024-09-30	8,063,348	21,550,000	37.42%
2024-06-30	8,689,119	21,062,000	41.25%
2024-03-31	196,021,280	20,368,000	-
2023-12-31	198,276,233	17,894,000	-
2023-09-30	195,285,774	18,908,000	-
2023-06-30	186,464,548	17,569,000	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

AGENUS INC (AGEN) — SEC Financial Statements & Analysis

AGENUS INC (AGEN) is a biological products, (no diagnostic substances) company, incorporated in DE. AGENUS INC trades on Nasdaq as: AGEN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), AGENUS INC reported a 30.47% year-over-year revenue growth, a Gross Profit Margin of 101.07% (TTM), a Debt-to-Equity ratio of -1.13x, a Price-to-Sales (P/S) ratio of 0.95x (TTM), a Price-to-Book (P/B) ratio of -0.61x (TTM), at a market cap of $126.49M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 30.47%
Gross Profit Margin TTM: 101.07%
Debt To Equity: -1.13x
P/S TTM: 0.95x
P/B TTM: -0.61x
Market Cap: $126.49M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is AGENUS INC in?

AGENUS INC (AGEN) operates in the Biological Products, (No Diagnostic Substances) industry.

What is AGEN's market cap?

AGENUS INC (AGEN) has a market capitalization of $126.49M as of 2026-06-30.

What is AGEN's P/E ratio?

AGENUS INC (AGEN)'s trailing twelve month P/E ratio is 1.36x as of 2026-06-30.

What exchange does AGEN trade on?

AGENUS INC (AGEN) trades on the Nasdaq.

Where is AGENUS INC incorporated?

AGENUS INC is incorporated in DE.

AGENUS INC

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

AGENUS INC (AGEN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

AGENUS INC (AGEN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.